The US Food and Drug Administration has doled out 27 emergency use authorizations (EUA) since the start of the month, and eight of those have been since 10 April. While there are indications social distancing may have helped stem the COVID-19 mortality rate in the US, the agency does not seem to be slowing down its efforts to get more products on the market to tackle the crisis.
On 10 April the FDA handed out a record six EUAs, the highest number since the start of the coronavirus pandemic. By comparison, the agency gave out just two EUAs...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?